Oncology Newswire

Oncology Newswire

Comprehensive Real-Time News Feed for Oncology.

Results 1 - 20 of 20,699 in Oncology

  1. Three like-minded nonprofits collaborate to launch immunotherapy...Read the original story w/Photo

    35 min ago | Medical News

    A Kids' Brain Tumor Cure Foundation, Solving Kids' Cancer and the Ty Louis Campbell Foundation announce their joint financial support of a Phase 1 clinical trial to test the safety and efficacy of combination checkpoint inhibitors in the treatment of children with brain tumors. The collaboration of these three like-minded nonprofits will result in a total contribution of $185,000 to bring this clinical trial to fruition for children battling brain tumors, today.

    Comment?

  2. Agenus Inc. (AGEN) Stock Rating Reaffirmed by Jefferies GroupRead the original story w/Photo

    55 min ago | Daily Political

    ... currently has a consensus rating of "Buy" and an average target price of $10.25. Agenus Inc (Agenus) is an immuno-oncology company. The Company is engaged in discovering and developing treatments for patients with cancer. Its approaches are driven ...

    Comment?

  3. Clovis Oncology Inc. (CLVS) Rating Reiterated by Piper Jaffray Cos.Read the original story w/Photo

    1 hr ago | AmericanBankingNews.com

    ... Jaffray Cos.'s price target indicates a potential downside of 37.39% from the company's previous close. Clovis Oncology ( NASDAQ:CLVS ) opened at 22.36 on Thursday. The firm has a 50-day moving average of $15.77 and a 200 day moving average of ...

    Comment?

  4. OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) Receives $20.50 Consensus PT from AnalystsRead the original story w/Photo

    2 hrs ago | Daily Political

    ... biopharmaceutical company. The Company focuses on discovering and developing anti-cancer stem cell (CSC) and immuno-oncology therapeutics. The Company's product candidates and preclinical programs include Demcizumab (Anti-DLL4, OMP-21M18), ...

    Comment?

  5. Celgene Corp. (CELG) Director James J. Loughlin Sells 27,500 SharesRead the original story w/Photo

    2 hrs ago | AmericanBankingNews.com

    ... of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Receive News & Ratings for Celgene Corp. Daily - Enter your email address ...

    Comment?

  6. America's Registry of Outstanding Professionals 2016...Read the original story w/Photo

    3 hrs ago | PR.com

    ... at the University of Texas Southwestern in Internal Medicine. She also completed a fellowship on Hematology/Oncology at Duke University Medical Center where she remained for several years until she moved to Pennsylvania. Dr. Littman is currently ...

    Comment?

  7. Merrimack Pharmaceuticals Inc (MACK) Now Covered by BTIG ResearchRead the original story w/Photo

    3 hrs ago | Daily Political

    ... medicines consisting of therapeutics paired with companion diagnostics for the treatment of cancer. Its therapeutic oncology candidates in clinical development include MM-398, MM-302, MM-121, MM-141 and MM-151. Receive News & Ratings for Merrimack ...

    Comment?

  8. Raysearch Laboratories AB (publ) Interim report January 1 - " June 30, 2016Read the original story

    3 hrs ago | P&T Community

    ... licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare, which comprises a new product area for RaySearch, and which will be launched in 2017. ...

    Comment?

  9. Inhibition of cholesterol metabolism underlies synergy between mTOR...Read the original story

    3 hrs ago | Oncogene

    Correspondence: Dr MA King or V Flemington, Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. E-mail: [email protected] or [email protected] Mutations to fibroblast growth factor receptor 3 and phosphatase and tensin homologue signalling pathway components pathway inhibitors and chloroquine —an anti-malarial drug used as a cancer therapy adjuvant in over 30 clinical trials.

    Comment?

  10. Weekly Investment Analysts' Ratings Changes for TrovaGeneRead the original story w/Photo

    4 hrs ago | AmericanBankingNews.com

    ... focus is to leverage its cell-free molecular diagnostic platform to facilitate improvements in the field of oncology, while its external focus includes entering into license agreements or collaborations to develop its technology in areas, such as ...

    Comment?

  11. Recent Research Analysts' Ratings Updates for TesaroRead the original story w/Photo

    4 hrs ago | Daily Political

    ... at Zacks Investment Research from a "sell" rating to a "hold" rating. According to Zacks, "Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 ...

    Comment?

  12. Weekly Investment Analysts' Ratings Changes for BioLineRxRead the original story w/Photo

    4 hrs ago | AmericanBankingNews.com

    ... in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases. " 8/14/2016 - BioLineRx had its "buy" rating reaffirmed by ...

    Comment?

  13. Targovax ASA: Interim Report second quarter and first half year 2016Read the original story

    4 hrs ago | P&T Community

    OSLO, Norway, Aug. 25, 2016 -- Targovax ASA , a clinical stage immuno-oncology company developing targeted immunotherapy treatments for cancer patients, announces its second quarter and first half year 2016 results. A meeting for investors, analysts and press will take place in Oslo today at 10:00 CET and a conference call will take place at 14.00 CET .

    Comment?

  14. Brave Darcie's rare cancer in remissionRead the original story w/Photo

    5 hrs ago | The Press On-Line

    ... would visit from Dunedin with their father. After ringing the "end of treatment bell" at the Children's Haematology Oncology Centre on Thursday, Darcie must now commit to an eight-to-ten year plan to manage her recovery, Willis said. Willis said the ...

    Comment?

  15. Data from Phase III Castor Study of Daratumumab Published in The New England Journal of MedicineRead the original story w/Photo

    6 hrs ago | GlobeNewswire

    The New England Journal of Medicine published data from the Phase III CASTOR study of daratumumab in relapsed or refractory multiple myeloma Copenhagen, Denmark; August 25, 2016 - Genmab A/S announced today The New England Journal of Medicine has published data from the Phase III CASTOR study of daratumumab. The CASTOR data were presented at the 2016 American Society of Clinical Oncology Annual Meeting and the 21st Congress of the European Hematology Association .

    Comment?

  16. Collaborative launch of immunotherapy clinical trial for children with brain tumorsRead the original story w/Photo

    6 hrs ago | EurekAlert!

    A Kids' Brain Tumor Cure Foundation, Solving Kids' Cancer and the Ty Louis Campbell Foundation co-fund research to to advance innovative new treatments for pediatric brain tumors September, 2016 - NEW YORK, NY: A Kids' Brain Tumor Cure Foundation, Solving Kids' Cancer and the Ty Louis Campbell Foundation announce their joint financial support of a Phase 1 clinical trial to test the safety and efficacy of combination checkpoint inhibitors in the treatment of children with brain tumors. The collaboration of these three like-minded nonprofits will result in a total contribution of $185,000 to bring this clinical trial to fruition for children battling brain tumors, today.

    Comment?

  17. Football inspired farewell for lifelong Canaries fan MichaelRead the original story w/Photo

    10 hrs ago | Evening News

    ... ll take place at Greenacres from 1.30pm followed by a private cremation. The family are asking for donations to the Oncology Department at Norfolk and Norwich University Hospital.

    Comment?

  18. Kura Oncology Inc. (KURA) Upgraded to "Hold" at Zacks Investment ResearchRead the original story w/Photo

    7 hrs ago | AmericanBankingNews.com

    According to Zacks, "Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers.

    Comment?

  19. Affirmed Therapeutics BV (AFMD) Shares Down 6.1%Read the original story w/Photo

    7 hrs ago | Daily Political

    ... vering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells.

    Comment?

  20. This test could help thousands of cancer patients avoid...Read the original story w/Photo

    8 hrs ago | Albany Times Union

    ... the group found "not statistically significant." In an accompanying editorial , the American Society of Clinical Oncology agreed that the MammaPrint test seemed to be a good tool for helping patients steer clear of chemotherapy when it might be ...

    Comment?